Magtein Secures UK Novel Food Approval; Omega-3 Supply Chain Database Launched
Magtein, a branded magnesium L-threonate, has gained UK novel food approval with a five-year data protection period, opening direct market opportunities for UK brands. Concurrently, GOED launched a new online database to enhance transparency and resilience in the omega-3 supply chain.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 23 March 2026
Magtein, a proprietary form of magnesium L-threonate, has received novel food approval from the UK Food Standards Agency (FSA) for England, Scotland, and Wales. This approval follows applications first submitted in 2021 and grants Magtein a five-year data protection period. Exclusively distributed in Europe by ThreoTech LLC, Magtein was originally developed in 2010 to enhance brain magnesium levels and has existing approvals in key markets including the EU (2024), US FDA GRAS (2012), Canada, Japan, and India. This UK authorisation enables manufacturers to incorporate Magtein into supplement formulations without extensive proprietary toxicology or safety studies, reducing R&D timelines and costs for new product development targeting cognitive function, mental wellbeing, and sleep support.
Simultaneously, the Global Organization for EPA and DHA Omega-3s (GOED) has launched an online database aimed at bolstering transparency across the omega-3 supply chain. The initiative, announced at the GOED Exchange 2026 in Singapore, currently lists 248 crude oil suppliers from 54 countries. This database, which includes details on regions served, certifications, production volumes, and EPA/DHA concentrations, was developed in response to the supply chain disruptions experienced during the 2023 fish oil shortage. Chris Gearheart, GOED’s Director of Sustainability & Analytics, highlighted that the database addresses critical industry questions about supplier knowledge during crises. A second phase, scheduled for later this year, will expand to include refined oil and concentrate producers, alongside more detailed omega-3 concentration and format data.
In other developments, new research published in Gut identified a positive association between the gut bacterium Roseburia inulinivorans and human muscle strength. Scientists noted higher abundance of R. inulinivorans in younger adults with superior grip strength and VO2max, as well as positive correlations with leg press and bench press strength. In older adults, detectable levels of the bacterium correlated with 29% higher handgrip strength. Animal studies further supported these findings, demonstrating increased muscle strength and fibre size with R. inulinivorans supplementation. This emerging science could inform future probiotic and synbiotic formulations targeting muscle health, particularly for ageing populations.
What this means for United Kingdom
UK brand owners can now directly formulate and launch products containing Magtein, capitalising on its five-year data protection without additional novel food hurdles. This provides a significant competitive advantage for first-movers in the cognitive and sleep support categories. For omega-3 procurement, the GOED database offers a critical tool for managing supply chain resilience, enabling UK manufacturers to diversify sourcing and verify supplier credentials, essential given ongoing geopolitical and environmental pressures on marine resources. The research into Roseburia inulinivorans opens new product development avenues in muscle health and healthy ageing, particularly for functional food and supplement brands looking to innovate beyond traditional protein and creatine offerings.
Many leading brands in this category are manufactured in partnership with Supplement Factory.